Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Davis Jerel. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Davis Jerel har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:TSBX / Turnstone Biologics Corp. | Director | 0 |
US:KDNY / Chinook Therapeutics Inc | Director | 0 |
US:RPTX / Repare Therapeutics Inc. | Director | 25 131 |
US:GRPH / Graphite Bio, Inc. | Director, 10% Owner | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Davis Jerel. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp RPTX / Repare Therapeutics Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i RPTX / Repare Therapeutics Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i RPTX / Repare Therapeutics Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Davis Jerel som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-08-08 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
U - Other | −82 006 | 0 | −100,00 | ||||
2025-08-08 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
U - Other | −90 888 | 0 | −100,00 | ||||
2025-08-08 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
U - Other | −207 486 | 0 | −100,00 | ||||
2025-08-08 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
U - Other | −2 726 322 | 0 | −100,00 | ||||
2025-08-08 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
U - Other | −274 990 | 0 | −100,00 | ||||
2023-08-11 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
D - Sale to Issuer | −210 996 | 0 | −100,00 | ||||
2023-08-11 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
D - Sale to Issuer | −719 104 | 0 | −100,00 | ||||
2023-08-11 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
D - Sale to Issuer | −2 105 107 | 0 | −100,00 | ||||
2023-08-11 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
D - Sale to Issuer | −447 013 | 0 | −100,00 | ||||
2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
P - Purchase | 5 939 | 82 006 | 7,81 | 12,00 | 71 268 | 984 072 | |
2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
P - Purchase | 6 575 | 90 888 | 7,80 | 12,00 | 78 900 | 1 090 656 | |
2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
P - Purchase | 15 028 | 207 486 | 7,81 | 12,00 | 180 336 | 2 489 832 | |
2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
P - Purchase | 197 458 | 2 726 322 | 7,81 | 12,00 | 2 369 496 | 32 715 864 | |
2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
C - Conversion | 274 990 | 274 990 | |||||
2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
C - Conversion | 76 067 | 76 067 | |||||
2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
C - Conversion | 84 313 | 84 313 | |||||
2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
C - Conversion | 192 458 | 192 458 | |||||
2023-07-27 |
|
4 | TSBX |
Turnstone Biologics Corp.
Common Stock |
C - Conversion | 2 528 864 | 2 528 864 | |||||
2023-05-31 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
M - Exercise | 3 300 | 733 770 | 0,45 | ||||
2023-04-19 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | −295 808 | 443 713 | −40,00 | 20,75 | −6 138 223 | 9 207 355 | |
2023-03-03 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | −36 751 | 210 996 | −14,83 | 22,75 | −836 085 | 4 800 159 | |
2023-03-03 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | −123 249 | 719 104 | −14,63 | 22,75 | −2 803 915 | 16 359 616 | |
2023-03-03 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | −240 000 | 2 105 107 | −10,23 | 22,75 | −5 460 000 | 47 891 184 | |
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 3 014 | 25 131 | 13,63 | ||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −4 721 | 0 | −100,00 | ||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 4 721 | 4 721 | |||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −21 854 | 42 877 | −33,76 | ||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 240 | 22 117 | 5,94 | ||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −65 957 | 0 | −100,00 | ||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 2 065 | 65 957 | 3,23 | ||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −9 561 | 18 761 | −33,76 | ||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 866 | 63 892 | 3,01 | ||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −8 638 | 16 949 | −33,76 | ||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 62 026 | 62 026 | |||||
2023-01-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −287 157 | 563 403 | −33,76 | ||||
2022-12-27 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 1 646 | 739 521 | 0,22 | ||||
2022-12-27 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −9 465 | 0 | −100,00 | ||||
2022-12-27 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 5 865 | 9 465 | 162,92 | ||||
2022-12-27 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −108 715 | 247 747 | −30,50 | ||||
2022-12-27 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 3 600 | 3 600 | |||||
2022-12-27 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −364 587 | 842 353 | −30,21 | ||||
2022-12-13 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
S - Sale | −250 000 | 2 094 451 | −10,66 | 16,00 | −4 000 000 | 33 511 216 | |
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −9 384 | 0 | −100,00 | ||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 9 384 | 9 384 | |||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 1 975 | 737 875 | 0,27 | ||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −11 359 | 0 | −100,00 | ||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 11 359 | 11 359 | |||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −567 963 | 2 345 107 | −19,50 | ||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 1 316 | 735 900 | 0,18 | ||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −7 570 | 0 | −100,00 | ||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 4 692 | 7 570 | 163,03 | ||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −86 972 | 356 462 | −19,61 | ||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 2 878 | 2 878 | |||||
2022-09-14 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −291 670 | 1 206 940 | −19,46 | ||||
2022-08-16 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 1 646 | 734 584 | 0,22 | ||||
2022-08-16 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −9 466 | 0 | −100,00 | ||||
2022-08-16 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 5 866 | 9 466 | 162,94 | ||||
2022-08-16 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −108 715 | 443 434 | −19,69 | ||||
2022-08-16 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 3 600 | 3 600 | |||||
2022-08-16 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −364 587 | 1 498 610 | −19,57 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 6 448 | 20 877 | 44,69 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −10 099 | 0 | −100,00 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 10 099 | 10 099 | |||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −46 753 | 64 731 | −41,94 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 2 653 | 14 429 | 22,53 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −141 103 | 0 | −100,00 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 4 419 | 141 103 | 3,23 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −20 454 | 28 322 | −41,93 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 3 992 | 136 684 | 3,01 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −18 478 | 25 587 | −41,93 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 132 692 | 132 692 | |||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −614 315 | 850 560 | −41,94 | ||||
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
S - Sale | −33 395 | 111 484 | −23,05 | 12,25 | −409 146 | 1 365 869 | |
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
S - Sale | −14 611 | 48 776 | −23,05 | 12,25 | −179 010 | 597 589 | |
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
S - Sale | −13 199 | 44 065 | −23,05 | 12,25 | −161 710 | 539 871 | |
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
S - Sale | −438 795 | 1 464 875 | −23,05 | 12,25 | −5 375 985 | 17 947 209 | |
2022-06-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
S - Sale | −250 000 | 2 344 451 | −9,64 | 12,25 | −3 062 925 | 28 723 510 | |
2022-05-16 |
|
4 | RPTX |
Repare Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 49 000 | 49 000 | |||||
2022-04-06 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −11 726 | 0 | −100,00 | ||||
2022-04-06 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 11 726 | 11 726 | |||||
2022-04-06 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 2 468 | 732 938 | 0,34 | ||||
2022-04-06 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | −14 194 | 0 | −100,00 | ||||
2022-04-06 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | 14 194 | 14 194 | |||||
2022-04-06 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
J - Other | X | −709 953 | 2 913 070 | −19,60 | |||
2022-01-05 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −92 000 | 552 149 | −14,28 | 16,00 | −1 472 018 | 8 834 494 |
2022-01-05 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −308 000 | 1 863 197 | −14,19 | 16,00 | −4 928 062 | 29 811 525 |
2022-01-05 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −600 000 | 3 623 023 | −14,21 | 16,00 | −9 600 120 | 57 969 093 |
2021-08-31 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | −78 098 | 644 149 | −10,81 | 14,00 | −1 093 372 | 9 018 086 | |
2021-08-31 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | −261 902 | 2 171 197 | −10,76 | 14,00 | −3 666 628 | 30 396 758 | |
2021-08-31 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Common Stock |
S - Sale | −510 000 | 4 223 023 | −10,78 | 14,00 | −7 140 000 | 59 122 322 | |
2021-08-09 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −2 260 | 0 | −100,00 | ||||
2021-08-09 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 2 260 | 2 260 | |||||
2021-08-09 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 19 | 11 776 | 0,16 | ||||
2021-08-09 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −2 279 | 0 | −100,00 | ||||
2021-08-09 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 2 279 | 2 279 | |||||
2021-08-09 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −152 071 | 231 211 | −39,68 | |||
2021-07-01 |
|
4 | GRPH |
Graphite Bio, Inc.
Series B Preferred Stock |
C - Conversion | −3 715 415 | 0 | −100,00 | ||||
2021-07-01 |
|
4 | GRPH |
Graphite Bio, Inc.
Series A Preferred Stock |
C - Conversion | −30 019 945 | 0 | −100,00 | ||||
2021-07-01 |
|
4 | GRPH |
Graphite Bio, Inc.
Common Stock |
P - Purchase | 180 000 | 1 707 719 | 11,78 | 17,00 | 3 060 000 | 29 031 223 | |
2021-07-01 |
|
4 | GRPH |
Graphite Bio, Inc.
Common Stock |
C - Conversion | 1 527 719 | 1 527 719 | |||||
2021-07-01 |
|
4 | GRPH |
Graphite Bio, Inc.
Common Stock |
C - Conversion | 12 343 727 | 14 708 398 | 522,01 | ||||
2021-06-28 |
|
4 | GRPH |
Graphite Bio, Inc.
Stock Option (right to buy) |
A - Award | 40 000 | 40 000 | |||||
2021-06-28 |
|
4 | GRPH |
Graphite Bio, Inc.
Series B Preferred Stock |
A - Award | 3 715 415 | 3 715 415 | 5,06 | 18 800 000 | 18 800 000 | ||
2021-06-28 |
|
4 | GRPH |
Graphite Bio, Inc.
Series A Preferred Stock |
A - Award | 10 000 000 | 30 019 945 | 49,95 | 1,00 | 10 000 000 | 30 019 945 | |
2021-06-24 | 3 | GRPH |
Graphite Bio, Inc.
Common Stock |
2 364 671 | ||||||||
2021-06-07 |
|
4 | KDNY |
CHINOOK THERAPEUTICS, INC.
Stock Option (Right to Buy) |
A - Award | 5 948 | 5 948 | |||||
2021-06-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −1 119 | 0 | −100,00 | ||||
2021-06-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 119 | 1 119 | |||||
2021-06-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 9 | 11 757 | 0,08 | ||||
2021-06-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −1 128 | 0 | −100,00 | ||||
2021-06-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 128 | 1 128 | |||||
2021-06-03 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −75 000 | 383 282 | −16,37 | ||||
2021-05-14 |
|
4 | RPTX |
Repare Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 21 000 | 21 000 | |||||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 912 | 11 748 | 8,42 | ||||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −3 473 | 0 | −100,00 | ||||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 3 473 | 3 473 | |||||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −16 079 | 144 879 | −9,99 | |||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 930 | 10 836 | 21,67 | ||||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −48 528 | 0 | −100,00 | ||||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 520 | 48 528 | 3,23 | ||||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −7 035 | 63 387 | −9,99 | |||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 373 | 47 008 | 3,01 | ||||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −6 355 | 57 264 | −9,99 | |||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 45 635 | 45 635 | |||||
2021-05-07 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −211 277 | 1 903 670 | −9,99 | |||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −745 | 0 | −100,00 | ||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 745 | 745 | |||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 6 | 8 906 | 0,07 | ||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −751 | 0 | −100,00 | ||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 751 | 751 | |||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −50 000 | 458 282 | −9,84 | |||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −5 176 | 0 | −100,00 | ||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 5 176 | 5 176 | |||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 824 | 8 900 | 10,20 | ||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −6 000 | 0 | −100,00 | ||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 6 000 | 6 000 | |||||
2021-02-18 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −300 000 | 2 594 451 | −10,36 | |||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −745 | 0 | −100,00 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 745 | 745 | |||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 6 | 8 076 | 0,07 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −751 | 0 | −100,00 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 751 | 751 | |||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −50 000 | 508 282 | −8,96 | |||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −4 313 | 0 | −100,00 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 4 313 | 4 313 | |||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 687 | 8 070 | 9,31 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −5 000 | 0 | −100,00 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 5 000 | 5 000 | |||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −250 000 | 2 894 451 | −7,95 | |||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 2 764 | 7 383 | 59,84 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −4 328 | 0 | −100,00 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 4 328 | 4 328 | |||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −20 037 | 160 958 | −11,07 | |||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 820 | 4 619 | 65,02 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −60 472 | 0 | −100,00 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 893 | 60 472 | 3,23 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −8 766 | 70 422 | −11,07 | |||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 711 | 58 579 | 3,01 | ||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −7 919 | 63 619 | −11,07 | |||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 56 868 | 56 868 | |||||
2021-02-02 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −263 278 | 2 114 947 | −11,07 | |||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −745 | 0 | −100,00 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 745 | 745 | |||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 6 | 2 799 | 0,21 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −751 | 0 | −100,00 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 751 | 751 | |||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −50 000 | 558 282 | −8,22 | |||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −4 744 | 0 | −100,00 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 4 744 | 4 744 | |||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 756 | 2 793 | 37,11 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −5 500 | 0 | −100,00 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 5 500 | 5 500 | |||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −275 000 | 3 144 451 | −8,04 | |||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 975 | 2 037 | 91,81 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −1 388 | 0 | −100,00 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 388 | 1 388 | |||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −11 688 | 180 995 | −6,07 | |||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 062 | 1 062 | |||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | −35 276 | 0 | −100,00 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 1 105 | 35 276 | 3,23 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −5 113 | 79 188 | −6,07 | |||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 998 | 34 171 | 3,01 | ||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −4 620 | 71 538 | −6,07 | |||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | 33 173 | 33 173 | |||||
2021-01-19 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −153 579 | 2 378 225 | −6,07 | |||
2020-12-17 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −21 707 | 192 683 | −10,13 | |||
2020-12-17 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −9 497 | 84 301 | −10,12 | |||
2020-12-17 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −8 579 | 76 158 | −10,12 | |||
2020-12-17 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
J - Other | X | −285 217 | 2 531 804 | −10,12 | |||
2020-10-07 |
|
4 | KDNY |
ADURO BIOTECH, INC.
Stock Option (right to buy) |
A - Award | 23 522 | 23 522 | |||||
2020-10-07 |
|
4 | KDNY |
ADURO BIOTECH, INC.
Common Stock |
A - Award | 2 433 099 | 2 433 099 | |||||
2020-10-07 |
|
4 | KDNY |
ADURO BIOTECH, INC.
Common Stock |
A - Award | 722 247 | 722 247 | |||||
2020-10-07 |
|
4 | KDNY |
ADURO BIOTECH, INC.
Common Stock |
A - Award | 4 733 023 | 4 733 023 | |||||
2020-10-07 |
|
4 | KDNY |
ADURO BIOTECH, INC.
Common Stock |
A - Award | 730 470 | 730 470 | |||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class B Preferred Shares |
C - Conversion | −458 282 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class B Preferred Shares |
C - Conversion | −875 568 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class B Preferred Shares |
C - Conversion | −3 350 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class B Preferred Shares |
C - Conversion | −3 708 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class B Preferred Shares |
C - Conversion | −8 475 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class B Preferred Shares |
C - Conversion | −111 361 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class A Preferred Shares |
C - Conversion | −2 443 883 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class A Preferred Shares |
C - Conversion | −61 791 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class A Preferred Shares |
C - Conversion | −68 398 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class A Preferred Shares |
C - Conversion | −156 335 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Class A Preferred Shares |
C - Conversion | −2 054 198 | 0 | −100,00 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
P - Purchase | 100 000 | 3 419 451 | 3,01 | 20,00 | 2 000 000 | 68 389 020 | |
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
P - Purchase | 150 000 | 608 282 | 32,73 | 20,00 | 3 000 000 | 12 165 640 | |
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 458 282 | 458 282 | |||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 875 568 | 3 319 451 | 35,83 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 3 350 | 84 737 | 4,12 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 3 708 | 93 798 | 4,12 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 8 475 | 214 390 | 4,12 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 111 361 | 2 817 021 | 4,12 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 2 443 883 | 2 443 883 | |||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 61 791 | 81 387 | 315,32 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 68 398 | 90 090 | 315,31 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 156 335 | 205 915 | 315,32 | ||||
2020-06-25 |
|
4 | RPTX |
Repare Therapeutics Inc.
Common Shares |
C - Conversion | 2 054 198 | 2 705 660 | 315,32 | ||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
1 393 792 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
791 910 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
764 022 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
761 926 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
1 393 792 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
791 910 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
764 022 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
761 926 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
1 393 792 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
791 910 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
764 022 | ||||||||
2020-06-18 | 3 | RPTX |
Repare Therapeutics Inc.
Common Shares |
761 926 |